Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Neuroleptic drugs in dementia: benefits and harm.

Ballard C, Howard R.

Nat Rev Neurosci. 2006 Jun;7(6):492-500. Review.

PMID:
16715057
2.

Developing treatment guidelines for Alzheimer's disease and other dementias.

Rabins PV.

J Clin Psychiatry. 1996;57 Suppl 14:37-8. Review.

PMID:
9024335
3.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
4.

[Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].

Gallarda T, Olie JP.

Encephale. 2000 May-Jun;26(3):72-80. Review. French.

PMID:
10951909
5.

Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.

Beier MT.

Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S9-17; quiz S24-5.

PMID:
17215476
6.

Treatment of dementia: anything new?

Machado JC, Caramelli P.

Curr Opin Psychiatry. 2006 Nov;19(6):575-80. Review.

PMID:
17012934
7.

Dementia and antipsychotic drugs.

Raskind MA, Risse SC, Lampe TH.

J Clin Psychiatry. 1987 May;48 Suppl:16-8.

PMID:
2883175
8.

Pharmacologic treatment of agitation associated with dementia.

Risse SC, Barnes R.

J Am Geriatr Soc. 1986 May;34(5):368-76. Review.

PMID:
2870097
9.

Current issues in dementia pharmacotherapy.

Daiello LA.

Am J Manag Care. 2007 Dec;13 Suppl 8:S198-202. Review.

10.

[An update on the treatment of psychological and behavioral symptoms associated to dementia].

Slachevsky A, Fuentes P.

Rev Med Chil. 2005 Oct;133(10):1242-51. Epub 2005 Dec 5. Review. Spanish.

11.

Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.

Lawlor B, Bhriain SN.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S2-6. Review.

PMID:
11748783
12.

Agitation and psychosis in dementia.

Ballard C.

Am J Geriatr Psychiatry. 2007 Nov;15(11):913-7. No abstract available.

PMID:
17974863
13.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5. Review.

PMID:
20684745
14.
15.

[Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].

Ruths S, Straand J.

Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1672-5. Review. Norwegian.

16.

Drugs for Alzheimer's disease and related dementias.

Gauthier S.

BMJ. 2005 Apr 16;330(7496):857-8. No abstract available.

17.

[Drug treatment of emotional and cognitive dysfunction in dementia].

Arsland D.

Tidsskr Nor Laegeforen. 1998 Feb 10;118(4):560-5. Review. Norwegian.

PMID:
9520584
18.

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association.

[No authors listed]

Am J Psychiatry. 1997 May;154(5 Suppl):1-39. No abstract available. Erratum in: Am J Psychiatry 1997 Aug;154(8):1180.

PMID:
9140238
19.

Risks and benefits of antipsychotic drugs in elderly patients with dementia.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Nov;46(11):19-23.

PMID:
19051574
20.

Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.

Grossman F, Okamoto A, Turkoz I, Gharabawi G.

J Am Geriatr Soc. 2004 May;52(5):852-3. No abstract available.

PMID:
15086685

Supplemental Content

Support Center